Nexalin Technology, Inc. has made a breakthrough with its Deep Intracranial Frequency Stimulation (DIFS™) technology, receiving official USPTO approval for a patent related to treating opioid use disorder (OUD) and substance use disorder (SUD). This non-invasive, drug-free solution offers hope for individuals struggling with addiction by regulating neural pathways linked to withdrawal symptoms. Mark White, CEO of Nexalin, sees this patent as a significant step in the field of addiction therapy, emphasizing the potential of DIFS™ to address core symptoms like anxiety and depression that drive chronic relapse. With millions worldwide affected by substance use disorders, Nexalin’s innovative approach aims to provide an alternative to traditional methods like medication-assisted therapy and behavioral interventions. David Owens, CMO of Nexalin, highlights the importance of new, non-invasive treatment options for addiction and mental health issues. This patent approval underscores Nexalin’s commitment to revolutionizing care standards in these areas. As the company expands its intellectual property portfolio, it remains dedicated to developing cutting-edge technology for addiction, mental health, and neurological disorders. For more information on Nexalin Technology and its advanced medical solutions, visit www.nexalin-usa.com. Through their non-invasive neurostimulation products, Nexalin strives to combat the global mental health epidemic by providing relief to those suffering from mental health issues. Their innovative technology penetrates deep brain structures associated with disorders, offering enhanced patient response without adverse side effects. With their Gen-2 neurostimulation device approved in multiple countries, Nexalin continues to lead the way in transforming patient care and recovery strategies.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
